Literature DB >> 31191129

Histomorphologic features of lung adenocarcinomas exhibiting ALK gene rearrangement.

Daniel S Grosser1, Haiying Zhang1.   

Abstract

With the advent of tyrosine kinase inhibitors, the identification of tumors with alterations in tyrosine kinase genes has become important to guide treatment. Lung adenocarcinomas harboring ALK translocations may be targeted with drugs such as crizotinib. We undertook a retrospective review of our institution's pathology records from January 2015 through September 2017 and identified 10 lung adenocarcinomas with ALK rearrangements. We reviewed the histomorphologic features and immunohistochemical results from these 10 cases. Morphologic features included patterns such as acinar, papillary, micropapillary, and solid, as well as features such as cribriform, signet ring, and extracellular mucin. Acinar (including simple and cribriform) was the most common pattern, followed by papillary. Solid and signet ring features were the least common. These findings were consistent with prior histomorphologic studies of ALK-positive lung adenocarcinomas. Certain histomorphologic patterns are associated with ALK positivity. However, histomorphologic features are neither absolutely sensitive nor absolutely specific in suggesting ALK rearrangement. Thus, identification of lung adenocarcinomas that may benefit from treatment with tyrosine kinase inhibitors requires comprehensive molecular testing.

Entities:  

Keywords:  ALK rearrangement; histomorphology; lung adenocarcinoma; tyrosine kinase inhibitors

Year:  2019        PMID: 31191129      PMCID: PMC6541054          DOI: 10.1080/08998280.2018.1559672

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  6 in total

1.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer.

Authors:  Makoto Nishio; Dong-Wan Kim; Yi-Long Wu; Kazuhiko Nakagawa; Benjamin J Solomon; Alice T Shaw; Satoshi Hashigaki; Emiko Ohki; Tiziana Usari; Jolanda Paolini; Anna Polli; Keith D Wilner; Tony Mok
Journal:  Cancer Res Treat       Date:  2017-07-06       Impact factor: 4.679

3.  Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas.

Authors:  Michiya Nishino; Veronica E Klepeis; Beow Y Yeap; Kristin Bergethon; Vicente Morales-Oyarvide; Dora Dias-Santagata; Yukako Yagi; Eugene J Mark; A John Iafrate; Mari Mino-Kenudson
Journal:  Mod Pathol       Date:  2012-06-29       Impact factor: 7.842

Review 4.  The anaplastic lymphoma kinase in the pathogenesis of cancer.

Authors:  Roberto Chiarle; Claudia Voena; Chiara Ambrogio; Roberto Piva; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

5.  ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.

Authors:  Yunjian Pan; Yang Zhang; Yuan Li; Haichuan Hu; Lei Wang; Hang Li; Rui Wang; Ting Ye; Xiaoyang Luo; Yiliang Zhang; Bin Li; Deng Cai; Lei Shen; Yihua Sun; Haiquan Chen
Journal:  Lung Cancer       Date:  2014-02-19       Impact factor: 5.705

6.  The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.

Authors:  Kyuichi Kadota; Yi-Chen Yeh; Camelia S Sima; Valerie W Rusch; Andre L Moreira; Prasad S Adusumilli; William D Travis
Journal:  Mod Pathol       Date:  2013-11-01       Impact factor: 7.842

  6 in total
  1 in total

1.  The Characteristics and Nomogram for Primary Lung Papillary Adenocarcinoma.

Authors:  Yuqian Zhang; Hui Xie; Ziying Zhang; Pengfei Zhang; Peng Chen; Xiang Wang
Journal:  Open Med (Wars)       Date:  2020-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.